Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop - Wikidata - wikimedia - TriplyDB

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

http://www.wikidata.org/entity/Q36740188

about

Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database.Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes Mechanisms of drug-induced liver injury: from bedside to bench.Losartan-induced Ischemic Hepatocellular Hepatotoxicity: A Case Report and Literature Review.Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population.A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report.Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.Lapatinib-induced hepatitis: a case report.Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China.Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.Clinical Features of Drug-induced Liver Injury According to Etiology.Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury.A human liver microphysiology platform for investigating physiology, drug safety, and disease models Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury Presentation and outcomes with clinically apparent interferon beta hepatotoxicity.Hepatotoxicity due to Clindamycin in Combination with Acetaminophen in a 62-Year-Old African American Female: A Case Report and Review of the Literature.Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.An Update on Drug-induced Liver Injury.Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.Drug-induced Liver Injury Associated with Mosapride Citrate: A Report of Two Cases.Drug-induced autoimmune-like hepatitis.Drug-induced liver injury: a summary of recent advances.Case definition and phenotype standardization in drug-induced liver injury.Genetic association studies in drug-induced liver injury.

P2860

Q26864098-68B7E0B8-CB25-42A6-B2D5-93138C8879A7 Q27006916-5EC75EAF-5773-4115-B0F4-5A026DD042BD Q27690772-51E90830-FD7B-42B7-92E3-C4D7395A0524 Q30843946-20B45475-DE77-4A65-A3B6-66B409FAF88D Q30852962-70393521-4C8B-48C0-BAC1-6A14747B4E81 Q33558782-38A09EB3-692B-4FC2-A671-ADB23E31CF2F Q33836130-92D90D68-A2FF-4ED0-BC09-B8E70BFFD52A Q34153004-1931FA4B-A249-41B5-9BCB-41C751F53AC5 Q34169362-1EEF049E-3D39-424B-A06C-505216FE80C8 Q34405954-DB7CE9A6-9145-423D-8434-D24B96802F48 Q34409744-0D315D13-7E0A-4DE7-8DE4-1B998E942748 Q34660447-069AC795-08B0-405D-A04A-186DCC9645F4 Q34818195-A5FC741F-9A89-4B81-BDEE-70339FB33A86 Q34848118-6490581E-4F0D-41D7-9DEA-E7765148C666 Q34993721-9714344E-3F1B-4292-82EC-2D77CB7AC478 Q35526652-DAA0913C-F284-4D06-9A6F-36DB539527A0 Q35771883-B2C1CBF7-D40C-41AD-A744-E92DBEB2151E Q36030977-845B6E83-A8EA-4684-A33D-A5CD84A4979C Q36094924-5E2111A7-1F34-41B9-9A96-011360B9A847 Q36153978-A6D35E83-3304-481D-A307-18633B726448 Q36378839-5BC0398A-DD9F-4D91-9DC7-382392E7D859 Q36400550-8EB4575F-10B6-4853-B085-8630290099A9 Q36405278-C85D18F8-0632-4E1F-84DA-09ECFF56A480 Q36491320-96A2CEF3-217D-464F-919A-0C07C0540089 Q36668891-9D0ECA7E-2417-4062-B956-6A8C9FC7C8EE Q36785642-5DEFE434-C847-4BAA-AE35-7B3257F46AF2 Q36790141-E27FA18E-13FA-4535-BA78-3CC8F55BF26E Q36845686-66AB7FC1-D36D-4444-94C5-050688495AAB Q36906633-9A3AC362-0206-4B19-ACD6-B7E8BF34F12A Q37100592-9F6A011C-FFE8-4FD8-97F1-8A46A148CC24 Q37232721-60CE61CB-0E32-4F65-8780-0D7E89694F30 Q37613520-D66D2748-4E29-4007-9EEF-47C3D93C1E0C Q37624916-E0140209-8D39-4C61-A132-8354AF833C8A Q37625519-50B03513-45B6-4628-8D98-7409720CF15D Q37636570-9E9A84D7-3513-490E-BAB4-DC4B4A022E2A Q37647432-90CAC59B-F937-43D6-98A8-D99C2B02CB09 Q37843783-064629AF-0EBC-42C2-A85A-CF73C7973510 Q37867695-6E92C485-4F3B-436B-95E6-5328A89B96D6 Q37872195-601328A2-2F69-416C-8E7A-9B7ECCC17E25 Q37931275-77EA360F-6912-49ED-B3AA-0EF52D5BA134

P2860

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

http://www.wikidata.org/entity/Q36740188

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Standardization of nomenclatur ...... f a clinical research workshop

@ast

Standardization of nomenclatur ...... f a clinical research workshop

@en

type

label

Standardization of nomenclatur ...... f a clinical research workshop

@ast

Standardization of nomenclatur ...... f a clinical research workshop

@en

prefLabel

Standardization of nomenclatur ...... f a clinical research workshop

@ast

Standardization of nomenclatur ...... f a clinical research workshop

@en

P1433

Q36740188-C10F696A-29A3-4262-94B5-2DECC998CD24

P1476

Q36740188-77F9FCE9-4773-44FE-B695-97DD023698A3

P2093

Q36740188-1B699AA6-3A7B-4FBD-9465-7B079AC7324A

Q36740188-54C1467E-F988-4B85-83C2-06F728B0F7F5

Q36740188-82EFCAEB-B0CE-43A6-A50E-358BC97CBB50

Q36740188-AF059706-26EF-4232-85CD-4CDB2DCA4023

Q36740188-B562996E-FAB5-4BAF-9419-6EF29F0BF098

Q36740188-DB4B03EF-13F9-43B9-BC49-4DB6D8B9B9BB

Q36740188-EF4B75E7-D2D0-43DA-98F1-620D10977F40

P2860

Q36740188-08244E30-ACDE-4EE1-9C89-D38A0C50D2B1

Q36740188-08F53E7A-45A3-4158-824F-5F153E040771

Q36740188-0D61DA18-4244-4A85-87B6-692CF9FCE4AB

Q36740188-142757E0-DC45-4E87-AF6F-D711E2CB10A7

Q36740188-1EAFBA1D-7FD4-48C7-B0AC-121C821B75C3

Q36740188-2305FF2D-0B2A-42C8-8286-1B1AF2FDBAD7

Q36740188-2B9EF1B3-A756-48F0-854C-5205943AAA5F

Q36740188-30AE3F2B-00D0-44C8-8E66-26590328755D

Q36740188-34C22B3E-4D21-46A9-AE24-BFCC029734FF

Q36740188-3637706D-27F6-4AB2-835D-90C6156C6C44

P304

Q36740188-AC7014BD-EBA2-4BF1-B023-55BA384BA660

P31

Q36740188-64813737-3F01-43AD-8E5D-806B1551FEB3

P356

Q36740188-C6B44947-0E55-431C-8D11-F53AE4B8036A

P407

Q36740188-EC2AF33A-F30E-46EB-BA54-213C75925F4F

P433

Q36740188-B873A08E-D605-4812-932C-CCBB3E2F6782

P478

Q36740188-C46842CE-E43E-49DB-90F2-0D4DD0B1558C

P577

Q36740188-2E0AF087-62CC-40F3-B041-E264D185D159

P5875

Q36740188-8F721FFB-5F4B-4551-9BD4-A989FA5BE56D

P698

Q36740188-9012C7EB-3A1C-4312-9B7E-FEC48906343A

P921

Q36740188-E1B9E9C8-5D39-4E77-8D09-C79F8D322A7B

P932

Q36740188-5DF7EFD9-4BF1-4DE2-8D94-46CF0ECE6E25

P356

P1433

P1476

Standardization of nomenclatur ...... f a clinical research workshop

@en

P2093

Christopher P Day

http://www.w3.org/2001/XMLSchema#string

Einar Björnsson

http://www.w3.org/2001/XMLSchema#string

Jay H Hoofnagle

http://www.w3.org/2001/XMLSchema#string

Jose Serrano

http://www.w3.org/2001/XMLSchema#string

Leonard B Seeff

http://www.w3.org/2001/XMLSchema#string

Raúl J Andrade

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.

Methotrexate and histologic hepatic abnormalities: a meta-analysis

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

A method for estimating the probability of adverse drug reactions

Hypersensitivity syndrome to antiepileptic drugs: a review including new anticonvulsants.

The natural history of histologically proved drug induced liver disease.

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

P304

730-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23696

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44689314

http://www.w3.org/2001/XMLSchema#string

P698

20564754

http://www.w3.org/2001/XMLSchema#string

P921

P932

3616501

http://www.w3.org/2001/XMLSchema#string